^™middle.

Gathering signals...

Truscreen (ASX:TRU) — Material Events

ASX:TRU · 5 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed

Major Score 90+

1

TruScreen Validated by Largest Study as Global Expansion AcceleratesMedium

TruScreen advances global cervical cancer screening with major clinical validation and market expansion

12 June 2026 ·Market Update ·90

Significant Score 75–89

3

Largest Global Study Validates TruScreen as Superior Cervical Cancer Screening ToolMedium

Largest global study validates TruScreen as superior cervical cancer screening tool

11 Feb 2026 ·Clinical Study Publication Announcement ·85

Sichuan Study Validates TruScreen’s AI Edge in Cervical Cancer ScreeningMedium

Sichuan University study confirms TruScreen + hr-HPV co-testing superior to Thinprep cytology for cervical cancer screening

9 Mar 2026 ·Clinical Study Announcement ·80

TruScreen Navigates H1 FY2026 Challenges, Eyes Growth with NZ$4m Capital BoostMedium

TruScreen reports H1 FY2026 sales decline, affirms FY revenue guidance, expands global screening programs and raises NZ$4m capital

28 Nov 2025 ·Results announcement ·75

Routine Score below 50

1

TruScreen Issues 1.7M Shares to Settle Marketing and Reward CFOMedium

TruScreen Group announces 1.7 million share placement for marketing services and CFO equity incentive

28 July 2025 ·Placement ·40

Not Assessed Low Score, or missing data

0

No articles in this tier for the last 12 months.

Market Mentions 5 - appeared in market wrap coverage

These are market wrap articles where Truscreen (ASX:TRU) was mentioned. They reflect broader market coverage, not company-specific announcements.

Market Wrap - Week 24 (8 June -> 12 June) 2026

Healthcare Wrap - Week 24 (8 June -> 12 June) 2026

Healthcare Wrap - Week 11 (9 Mar -> 13 Mar) 2026

Market Wrap - Week 7 (9 Feb -> 13 Feb) 2026

Healthcare Wrap - Week 7 (9 Feb -> 13 Feb) 2026